Clin2
NCT06201858Likely a fitNot yet recruiting

Understanding daily experiences with hidradenitis suppurativa

Hidradenitis Suppurativa

Part of Infections, Skin clinical trials.

This study tracks the daily experiences of people living with hidradenitis suppurativa to learn more about their symptoms and treatment patterns. By participating, you help doctors better understand this condition, which could lead to improved care and support.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be at least 18 years old.
  • You must have been diagnosed with hidradenitis suppurativa (a chronic skin condition that causes painful bumps and boils).
  • You must be able to understand the study and give your permission to take part.
  • You cannot be pregnant or nursing during the study.
  • You must be able to regularly report your symptoms electronically, like through a smartphone or computer app.
  • You must not have severe psychiatric or substance abuse issues that would make it hard to follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03967600Recruiting
Study of hidradenitis suppurativa skin features

This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.

San Francisco, California
NCT04115566Recruiting
HS patient registry and sample storage study

This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.

San Francisco, California
NCT06895499Recruiting· Phase 1/Phase 2
Testing a new drug for hidradenitis suppurativa

This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.

Jinan, Shandong
NCT05531747Recruiting
Study of stress in skin stem cells in hidradenitis

This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.

Créteil, Val-de-marne
NCT07136467Recruiting
Understanding daily life with vitiligo, alopecia areata, or hidradenitis suppurativa

This study looks at how certain skin conditions affect daily life in teens and adults. Researchers want to understand the challenges people face with vitiligo, alopecia areata, or hidradenitis suppurativa by having participants fill out simple questionnaires.

Ciudad Autonoma de Buenos Aire, Buenos Aires
NCT06370052Not yet recruiting
Understanding the causes of hidradenitis suppurativa

This study looks at the underlying causes of hidradenitis suppurativa (HS), a skin condition that causes painful lumps. By joining, you help researchers understand the disease better, which could lead to improved treatments.

Hear when a new Hidradenitis Suppurativa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.